Npr iconNprAug 27, 2026

FDA approves landmark pancreatic cancer drug that's shown to improve survival

health officials have approved a groundbreaking pancreatic cancer drug that offers a new approach to treating the deadly form of cancer, by blocking a protein that fuels tumor growth in the vast majority of cases.

FDA approves landmark pancreatic cancer drug that's shown to improve survival

Share this story

Send the public story page.

Useful takeaways from this story.

health officials have approved a groundbreaking pancreatic cancer drug that offers a new approach to treating the deadly form of cancer, by blocking a protein that fuels tumor growth in the vast majority of...

Building the complete brief

The page is ready to read now. The fuller skim-friendly version will appear here automatically.

The useful part

health officials have approved a groundbreaking pancreatic cancer drug that offers a new approach to treating the deadly form of cancer, by blocking a protein that fuels tumor growth in the vast majority of cases.

Keep reading in the app

Open the app view to save this story, compare related coverage, and continue from the same source.

Open in app